CHINA PHARMA HOLDINGS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
China Pharma Holdings, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • China Pharma Holdings, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $58.9K, a 56.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $58.9K -$75.3K -56.1% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $77.3K -$75.1K -49.3% Jun 30, 2024 10-Q 2024-08-14
Q4 2023 $117K +$77.6K +199% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $134K +$76.8K +134% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $152K +$71.4K +88.1% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $19.8K -$87.3K -81.5% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $39K -$88.9K -69.5% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $57.5K -$89.3K -60.9% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $81K -$88.8K -52.3% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $107K +$81.7K +322% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $128K +$78.3K +158% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $147K +$76K +107% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $170K +$79.5K +88.1% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $25.4K -$87.1K -77.4% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $49.7K -$87.1K -63.7% Dec 31, 2020 10-K 2022-03-30
Q3 2020 $70.7K -$86.4K -55% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $90.3K -$94.3K -51.1% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $112K -$100K -47.1% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $137K Dec 31, 2019 10-K 2021-03-26
Q3 2019 $157K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $185K Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $213K Mar 31, 2019 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.